Filing Details

Accession Number:
0001209191-11-042870
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-08 13:00:00
Reporting Period:
2011-08-08
Filing Date:
2011-08-08
Accepted Time:
2011-08-08 16:08:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1232505 J Robert Hugin C/o Celgene Corporation
86 Morris Avenue
Summit NJ 07901
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-08 10,000 $52.70 429,252 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,800 Indirect By children
Common Stock 13,021 Indirect 401(k) Plan
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.